Treatment of Complex PTSD
- Conditions
- Complex PTSDPhase-based treatmentTrauma-focusedEMDRSTAIRComplexe PTSSTraumagerichtGefaseerde behandeling
- Registration Number
- NL-OMON22074
- Lead Sponsor
- niversity of Amsterdam UvAUniversity of Groningen RuG
- Brief Summary
1. Study protocol.<br> 2. Article about the results of the RCT in which phase-based treatment versus directe trauma-focused treatment are compared in patients with Complex PTSD.<br> 3. Article about cost-effectiveness of both treatments.<br> 4. Article about predictors and moderators in the treatment of Complex PTSD.<br> 5. Article about possible predictors of worse outcome and drop-out in the treatment of Complex PTSD.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 122
In order to be eligible to participate in this study, a patient must meet all of the following criteria: a) meeting the criteria for PTSD, according to the Clinical-Administered PTSD Scale for DSM-5 (CAPS-5; Weathers et al., 2013), b) having symptoms of Complex PTSD, c) reporting a history of repeated physical and/or sexual abuse by a caretaker or person in authority during childhood (before the age of 18), d) being in the age between 18 and 65 years, e) giving an informed consent for study participation.
A patient who meets any of the following criteria will be excluded from participation in this study: a) insufficient competence in speaking the Dutch language, b) high risk of suicidality assessed by the BDI-II (Beck, Steer, and Brown, 1996), c) currently in treatment for PTSD, d) severe alcohol or drug dependence or abuse, e) IQ under 80, and f) victim of ongoing physical and/or sexual abuse.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Severity of PTSD symptoms
- Secondary Outcome Measures
Name Time Method Secondary parameters include the presence of a PTSD diagnosis, severity of Complex PTSD symptoms and comorbid symptoms (i.e., anxiety, depression, general psychopathology), dissociation, health-related quality of life and drop out during treatment in both conditions.